Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases

References

• Mascarello A, Chiaradia-Delatorre LD, Mori M, et al. Mycobacterium tuberculosis-secreted tyrosine phosphatases as targets against tuberculosis: exploring natural sources in searching for new drugs. Curr Pharm Des 2016;22:1561–9.
   PubMed Web of Science ®Google Scholar
• Rudolph J. Cdc25 phosphatases: structure, specificity, and mechanism. Biochemistry 2007;46:3595–604.
   PubMed Web of Science ®Google Scholar
• Ducommun B, Draetta G, Young P, Beach D. Fission yeast cdc25 is a cell-cycle regulated protein. Biochem Biophys Res Commun 1990;167:301–9.
   PubMed Web of Science ®Google Scholar
• Boutros R, Lobjois V, Ducommun B. CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation. Cancer Res 2007;67:11557–64.
   PubMed Web of Science ®Google Scholar
• Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2007;7:495–507.
   PubMed Web of Science ®Google Scholar
• Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol 2004;11:1043–51.
   PubMed Web of Science ®Google Scholar
• Brenner AK, Reikvam H, Lavecchia A, Bruserud O. Therapeutic Targeting the Cell Division Cycle 25 (CDC25) phosphatases in human acute myeloid leukemia – the possibility to target several kinases through inhibition of the various CDC25 isoforms. Molecules 2014;19:18414–47.
   PubMed Web of Science ®Google Scholar
• Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006;18:185–91.
   PubMed Web of Science ®Google Scholar
• Cangi MG, Cukor B, Soung P, et al. Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 2000;106:753–61.
   PubMed Web of Science ®Google Scholar
• Bonin S, Brunetti D, Benedetti E, et al. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer. Virchows Arch 2006;448:539–44.
   PubMed Web of Science ®Google Scholar
• Lavecchia A, Di Giovanni C, Novellino E. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy. Curr Med Chem 2009;16:1831–49.
   PubMed Web of Science ®Google Scholar
• Brault L, Bagrel D. Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells. Life Sci 2008;82:315–23.
   PubMed Web of Science ®Google Scholar
• Lazo JS, Aslan DC, Southwick EC, et al. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J Med Chem 2001;44:4042–9.
   PubMed Web of Science ®Google Scholar
• Lavecchia A, Di Giovanni C, Novellino E. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review. Expert Opin Ther Pat 2010;20:405–25.
   PubMed Web of Science ®Google Scholar
• Contour-Galcera MO, Lavergne O, Brezak MC, et al. Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett 2004;14:5809–12.
   PubMed Web of Science ®Google Scholar
• He R, Zeng LF, He Y, et al. Small molecule tools for functional interrogation of protein tyrosine phosphatases. FEBS J 2013;280:731–50.
   PubMed Web of Science ®Google Scholar
• Brisson M, Foster C, Wipf P, et al. Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone. Mol Pharmacol 2007;71:184–92.
   PubMed Web of Science ®Google Scholar
• Georgantea P, Ioannou E, Evain-Bana E, et al. Sesquiterpenes with inhibitory activity against CDC25 phosphatases from the soft coral Pseudopterogorgia rigida. Tetrahedron 2016;72:3262–9.
   Web of Science ®Google Scholar
• Brezak MC, Valette A, Quaranta M, et al. IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. Int J Cancer 2009;124:1449–56.
   PubMed Web of Science ®Google Scholar
• Brezak MC, Quaranta M, Contour-Galcera MO, et al. Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Mol Cancer Ther 2005;4:1378–87.
   PubMed Web of Science ®Google Scholar
• Brezak MC, Quaranta M, Mondesert O, et al. A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res 2004;64:3320–5.
   PubMed Web of Science ®Google Scholar
• Monks TJ, Hanzlik RP, Cohen GM, et al. Quinone chemistry and toxicity. Toxicol Appl Pharmacol 1992;112:2–16.
   PubMed Web of Science ®Google Scholar
• Monks TJ, Jones DC. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr Drug Metab 2002;3:425–38.
   PubMedGoogle Scholar
• Ollinger K, Brunmark A. Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes. J Biol Chem 1991;266:21496–503.
   PubMed Web of Science ®Google Scholar
• Brault L, Denance M, Banaszak E, et al. Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases. Eur J Med Chem 2007;42:243–7.
   PubMed Web of Science ®Google Scholar
• Valente S, Bana E, Viry E, et al. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases. Bioorg Med Chem Lett 2010;20:5827–30.
   PubMed Web of Science ®Google Scholar
• Hawkins PC, Skillman AG, Warren GL, et al. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model 2010;50:572–84.
   PubMed Web of Science ®Google Scholar
• OpenEye. OMEGA 2.5.1.4: OpenEye Scientific Software, Santa Fe, NM. Available from: http://www.eyesopen.com.
   Google Scholar
• McGann M. FRED pose prediction and virtual screening accuracy. J Chem Inf Model 2011;51:578–96.
   PubMed Web of Science ®Google Scholar
• McGann M. FRED and HYBRID docking performance on standardized datasets. J Comput Aided Mol Des 2012;26:897–906.
   PubMed Web of Science ®Google Scholar
• OpenEye. FRED 3.0.1 OpenEye Scientific Software, Santa Fe, NM. Available from: http://www.eyesopen.com.
   Google Scholar
• Wang RX, Lai LH, Wang SM. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput-Aided Mol Des 2002;16:11–26.
   PubMed Web of Science ®Google Scholar
• Miller BR, McGee TD, Swails JM, et al. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 2012;8:3314–21.
   PubMed Web of Science ®Google Scholar
• Mori M, Manetti F, Botta M. Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators. J Chem Inf Model 2011;51:446–54.
   PubMed Web of Science ®Google Scholar
• Fauman EB, Cogswell JP, Lovejoy B, et al. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell 1998;93:617–25.
   PubMed Web of Science ®Google Scholar
• Reynolds RA, Yem AW, Wolfe CL, et al. Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol 1999;293:559–68.
   PubMed Web of Science ®Google Scholar
• UniProt C. UniProt: a hub for protein information. Nucleic Acids Res 2015;43:D204–12.
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947–8.
   PubMed Web of Science ®Google Scholar
• Sali A, Blundell TL. Comparative Protein modeling by satisfaction of spatial restraints. J Mol Biol 1993;234:779–815.
   PubMed Web of Science ®Google Scholar
• Noland WE, Kedrowski BL. Quinone approaches toward the synthesis of aflatoxin B(2). Org Lett 2000;2:2109–11.
   PubMed Web of Science ®Google Scholar
• Lanfranchi DA, Hanquet G. Asymmetric Diels-Alder reactions of a new enantiomerically pure sulfinylquinone: a straightforward access to functionalized Wieland-Miescher ketone analogues with (R) absolute configuration. J Org Chem 2006;71:4854–61.
   PubMed Web of Science ®Google Scholar
• Lanfranchi DA, Bour C, Hanquet G. Enantioselective access to key intermediates for salvinorin A and analogues. Eur J Org Chem 2011;2818–26.
   Web of Science ®Google Scholar
• Lavecchia A, Di Giovanni C, Novellino E. CDC25 phosphatase inhibitors: an update. Mini Rev Med Chem 2012;12:62–73.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011;51:69–82.
   PubMed Web of Science ®Google Scholar
• Mori M, Botta M. Drug design and screening by in silico approaches. Trypanosomat Dis Mol Routes Drug Disc 2013;57–79.
   Google Scholar
• Infante P, Mori M, Alfonsi R, et al. Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO J 2015;34:200–17.
   PubMed Web of Science ®Google Scholar